SEC Form 4 · accession 0001209191-19-004478
Arcus Biosciences, Inc. · RCUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juan C. Jaen
Officer — President · Director
Period of report
Jan 16, 2019
Accepted (ET)
Jan 18, 2019 · 1:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724521
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.36 | Jan 16, 2019 | A | 200,000 | A | — | Jan 15, 2029 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The option is exercisable in 48 equal monthly installments after January 16, 2019, subject to the Reporting Person's continued service to the Company.